438 A phase 1 trial of CUE-101, a novel HPV16 E7-pHLA-IL2-Fc fusion protein, alone and in combination with pembrolizumab in patients with recurrent/metastatic HPV16+ head and neck... von Chung, Christine, Dimitrios Colevas, A, Gibson, Michael, Adkins, Douglas, Sukari, Ammar, Wirth, Lori, Burtness, Barbara, Bauman, Julie, Rodriguez, Cristina, Worden, Francis, Saba, Nabil, Glisson, Bonnie, Dunn, Lara, Seiwert, Tanguy, Agensky, Laura, Levisetti, Matteo, Lynam, Reena, Margossian, Steven, Moniz, Raymond, Quayle, Steve, Pienta, Kenneth, Pai, Sara

Volltext

636 A phase 1, open-label, dose escalation and expansion study of CUE-102 monotherapy in HLA-A0201 positive patients with WT1-positive recurrent/metastatic cancers von Margossian, Steven, Powderly, John, Nashat Gabrail, Saenger, Yvonne, Selfridge, J Eva, Uboha, Nataliya, Gong, Jun, Brian Van Tine, Alese, Olatunji, Kim, Dae Won, Ma, Wen, Bekaii-Saab, Tanios, Jones, Jeremy, Alistar, Angela, Agensky, Laura, Goel, Apollina, Lynam, Reena, Moniz, Raymond, Quayle, Steve, Rajan, Cynthia, Pienta, Kenneth, Levisetti, Matteo

Volltext